Member Info for Bantham

BVista - i am afraid i don’t agree.

Destiny has now put out two poorly considered RNS’s this year. They just both seem muddled.

That raises questions about what’s going on.

It’s really important for small companies to communicate well - whether things are going great or whether issues have arisen. This company is failing to do that and that should matter to LTH’s.

In particular it’s opaque messaging on NTCD-M3.

I take it as negative. So does the market. So why not be really clear. What does Chris’s quote on this even mean?

Really off the pace.

Agreed. Last two communications very poorly thought out.

Unimpressed.

It’s a shame as historically they have been thoughtful around communication.

Bojo - you have been misled. Very few companies pay for research for the simple reason that no-one believes it as it is not independent.

No company in the FTSE 350 will pay for research.

And most below that won’t either.

If you don’t believe me, then just find 1 company in the FTSE 350 who does. That should be pretty easy.

But you know. - who cares whether it is paid for or not? i mean if you want to rely on that research note when they specifically tell you that you shouldn’t, go ahead. No doubt you will make a fortune :)

Agreed.

What amazes me is the nonchalance of so many LTH’s on the Balance sheet. The cash is pretty much spent by the year end and - it seems to me - a lot more will be required just to keep the lights on after that. So to the obvious question - who is going to fund a [£15m] ask? It has to be II’s. But there aren’t any [ yes i very slightly exaggerate EC to illustrate the problem ]. If that isn’t risky i don’t know what is.

But our ramping friends say - ‘ no worries, there’s £15m of cash and that takes us through to 2H 2025’.

Well even if that’s not massively risky from a funding requirement ( which it is ) have you guys ever thought about how potential customers might look at the situation? You think ‘ big pharma’ doesn't look at Balance Sheets and the ability to deliver longterm.? Well i have news for you - that’s exactly what they do. And Angle’s balance sheet won’t be appealing to these counterparties.

Constantly amazes me how people ignore obvious warning signs when their eyes are focussed on a massive prize over the horizon.

IMO DYOR please

I don’t think so DG.

IR’s main job is to build II relationships - which is exactly what Angle needs. No II will pay any attention to paid for research - they will run their own models. They would perhaps have paid attention to research from Jeffries - or at least that would have got on their desks.

So who is the audience for this stuff? We are……

Just to be totally clear - note the following in the disclaimer:

‘Research on its client companies produced by TDRL is normally commissioned and paid for by those companies themselves (‘issuer financed research’) and as such is not deemed to be independent, as defined by the FCA, but is ‘objective’ in that the authors are stating their own opinions. The report should be considered a marketing communication for purposes of the FCA rules. ‘

In other words, Angle has money to commission stuff like this but can’t afford an IR director to develop institution relationships.

Go figure….

And DYOR

Sandy - thanks for this.

A few points.

Valuation - even based on massive hope value they only get to 67p. Note the discount rate for the DCF is only 10%.

How many times do they note how difficult it is / going to be to get commercial traction?

It’s a corporate client - so this is ‘ paid for research’ i think.

It’s clear they think the best route to market would require much more cash: ‘ Although an internally developed complete “sample-to-answer” approach would arguably retain more value, we believe that in order to realise the commercial potential a meaningful installed base would need to be established, which would take time and require substantial additional investment. ‘

They forecast just £4m of cash at year end. No surprise there - but let that focus minds for a moment for people who think they can delay a raise into 2025.

This is not something for the LTH’s to take comfort from. Quite the opposite.

DYOR - seriously

Hi Sajy - where did you pick up that the company already have the results? I can’t see that.

Good analysis in my opinion JTIT.

I too became very concerned about announcements that never seemed to lead anywhere.

AN is very strong on the announcement of ‘ breakthroughs’ but doesn’t have much of a track record on delivery.

One of the many red flags related to Angle and its BoD.

That’s why all the longs here are just hoping for a dream to come true. Maybe it will this time but history suggests otherwise.

I note we are pretty much back to the price before the latest ‘ breakthrough’ . All that tells you is the hot money flooded in and ramped up the price and then it left and , surprise surprise, the price dropped back down. In the meantime some people lost a huge percentage of their investment based on the ramping.

Ok - thanks Mr Griffiths. Comments withdrawn.

Don’t be so pompous Mr Giffiths. This site is a bit of entertainment. No-one takes any notice of anyone else’s views - which is probably a good thing. EC / TG2D - don’t take it so seriously. Except bear in mind that EC made money at the top so maybe he’s worth listening to?

And glad you had a chance to chat to Brett. Your opinion on him is very important despite no links to RNS’s / other sources. BTW - you mind verifying your discussion in some way in line with your advice to the rest of us?

And could you clear something else up for me? You have clearly forgotten that you apparently filtered TG2D some time ago. Did you forget you told us that or did you miss his posts and unfilter him? Either way - let’s at least always try to tell the truth shall we ( if that doesn't sound too pompous )?

Hope you enjoyed it EC. I was trying to copy your style - with a twist! Just for fun.

Actually you were smart because you sold a slice at 30p. Always a good plan that i don’t do enough.

Anyway - i would like you / the LTH’s to make money. You deserve it for all the pain Newland has inflicted on you.

Berenburg - the in-house broker - have a longstanding price target of 120p - that’s SEVEN TIMES UPSIDE. I am assured the analyst is very smart.

Directors bought at 80p in the Placing - just because other investors probably required them to is irrelevant .

Lot’s of people think II’s have been piling into this - although sadly no TR1’s yet for new institutions. But it must be the case that lots of II’s are looking closely. I mean they wouldn’t want to miss out would they?

Lot’s of people think the Directors have been buying recently - i mean why wouldn’t they at these prices?! And if they haven’t it’s because they are privy to exciting price sensitive information or maybe a takeover at 200p. Just imagine how many BIG Pharma are spending all their time thinking about Angle and working out their plans for a takeover?

Golden Cross at 47p just the other day

Lots of cash - out to Q2 2025 - that’s more than a year before we completely run out of money. If that isn’t a fortress balance sheet i don’t know what is.

Directors recently implying that they may never need to raise cash at all - assuming they can sign more contracts.

So no need to think about a capital raise .

Amazing contracts flying through the door.

The Eisai one was worth an incredible $250k over some indeterminate period of time. That’s pretty cool. BTW - Eisai is a MAJOR Pharma company

Anyway, given half the chance that one contract has the potential to become $900m sales per annum. If you do the maths. - that’s worth a lot more than the current market cap

And then they just had an amazing BREAKTHROUGH. Just the news of the BREAKTHROUGH tripled the share price. Everyone must agree that’s pretty amazing

And yet again they have done something else with the potential to to do something pretty cool sometime in the future - so cool that they just announced it.

Everyone wants a piece of this.

I am not sure why so many of the rampers moved on but i am certain they will be back as there is so much incredible news flow

Also let’s not forget the Board of Directors.

Incredible track record of value creation.

And they’ve laid out a really clear story of financial growth.

And can you believe you can buy a piece of this for just 17p. That’s the DEAL OF THE CENTURY.

But remember DYOR as maybe i haven’t understood exactly what is going on here

What does that mean please?

Only significance would be that they weren’t impressed with Cavendish - and therefore they have been removed.

Otherwise nothing to see here.

Personally i think they need to think harder about their communications. The update a couple of weeks ago was neither clear nor enlightening. They have work to do.

I don’t know even where to start on that tom. Sometime back i thought you might have a finance / trading / advisory background. But pretty much everything you say now demonstrates that’s unlikely ( or you have forgotten some pretty simple things).

Anyway - enough from me. I am switching off from looking at this fo0lishness for a while. So i won’t challenge your happy delusions.

Sanji and TG2D - this board is full of suckers and delusional dreamers. They have committed themselves to an idea that they will make five, ten 100 times their money. And they can’t hear different views.

TomHuk is, he tells us, a long term buyer. But he posts incessantly every day. Thats not really what long term holders do is it.

ATM the share price is simply a function of hot money going in and out at different moments. Who can say why it does one thing one morning and another in the afternoon? That’s the nature of hot money.. There are no institutions coming into this. And the punters seem to have no curiosity for why that may be. I have no idea where the share price will go over the next month. But i am pretty sure a nasty shock awaits these guys down the line.

Your words TomHuk :’ If a company that you term as "mid to large" like Eisai rolled out the Parsortix system throughout their 60,000+ participant studies (as hypothesised in the presentation) and were paying out $180,000,000 to $900,000,000 ($1000-$5000 per text as quoted in the presentation - I don't want you accusing me of making stuff up). Then why not buy the company for £250,000,000+?’

Ramping away and then pretending you didn’t say this.

Sure - i was wrong on 12th Dec. And you made some money. But that doesnt mean i am wrong about this company. After all i was correct all the way down from £1. And i wouldn’t think of giving you investment advice as you are clearly an excellent researcher :)

That’s ok synoogold

I saw you forecast the shares to go above 40p on 5th January. And then you said:

‘Yup, this will move at lightning speed when it rises. This morning after initial drop jumped over 7p in 40 minutes.

Brace yourself for later. Next week will be spectacular rise. Some clever folks are hoovering up !!!’

That comment was at 30p.

Plus you forecast more TR1’s.

Odd how none have materialised despite all the volume. I mean where are all those institutional buyers?

So for someone as clueless as you i can see you need someone to help clarify the implications of what Mr Newland said.